Perioperative blood transfusion and solid tumor recurrence--a review. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Perioperative blood transfusion and solid tumor recurrence--a review.

Cancer Invest. 1987;5(6):615-25. Unique Identifier : AIDSLINE MED/88164484
Blumberg N; Heal JM; Blood Bank, Strong Memorial Hospital, Rochester, New York.

Abstract: Evidence regarding the association of blood transfusions with recurrence of solid tumors is largely conflicting. This is perhaps not surprising given the retrospective nature of the studies, the complexity of the disease and its treatment, and variations in local transfusion practices. Nonetheless, data demonstrating that transfusions of whole blood are associated with earlier cancer recurrence are most readily explained by a cause and effect relationship. There is a growing literature documenting previously unforeseen immunologic consequences of homologous blood transfusion. These possible clinical consequences may include earlier cancer recurrence, and increased susceptibility to infection with bacteria and viruses. The questions raised in this review will likely be answered by further studies. For the present, the prudent clinician will select red blood cells rather than whole blood for transfusion, and recognize that blood transfusion is a therapy with considerable benefits, but also considerable risks.
Keywords: Acquired Immunodeficiency Syndrome/ETIOLOGY Blood Transfusion/*ADVERSE EFFECTS Erythrocytes/TRANSPLANTATION Human Neoplasm Recurrence, Local/*ETIOLOGY Neoplasms/MORTALITY JOURNAL ARTICLE REVIEW REVIEW, ACADEMIC

KWDacquiredimmunodeficiencysyndrome/etiologybloodtransfusion/KWDadverseeffectserythrocytes/transplantationhumanneoplasmrecurrence,local/KWDetiologyneoplasms/mortalityjournalarticlereviewreview,academic
880730
M8870439

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .